Janet Li, MD
Gynecology · Quincy, MANPI 1003882564
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,000 of the $7,632 with a category attached, or 78.6%. Intuitive Surgical accounts for 78.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $6,015 and has fallen 94.7% since, to $321 in 2025. Among gynecology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $381.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Medtronic$984
- Boston Scientific$376
- Coloplast$157
- AbbVie$100
- Boehringer Ingelheim$15
What the payments were for
- Travel & lodging$80211%
- Food & beverage$83011%
- Education$6,00079%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 2 | $6,000 |
| Medtronic(2 entities) | 11 | $984 |
| Boston Scientific | 4 | $376 |
| Coloplast | 1 | $157 |
| AbbVie | 1 | $100 |
| Boehringer Ingelheim | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$6,000
- INTERSTIM$722
- Axonics$175
- ALTIS$157
- UPSYLON$110
How this compares
$7,632 in reported general payments places this provider in the 90th percentile of 74 gynecology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 243 | $156,360 |
| GemtesaVibegron | 109 | $77,241 |
| Estradiol | 128 | $16,868 |
| Mirabegron ErMirabegron | 32 | $14,538 |
| EstringEstradiol | 28 | $14,250 |
| YuvafemEstradiol | 40 | $6,250 |
| Trospium Chloride | 22 | $1,447 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 51 | $331 |
| Ciprofloxacin Hcl | 56 | $136 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $95 |
| Ibuprofen | 29 | $63 |
| Cephalexin | 15 | $43 |
| Oxycodone Hcl | 33 | $39 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Quincy
- Jon EinarssonBoston$67K
- Angel JohnsonNew York$63K
- Tesia KimBoston$52K
- Julia EdelmanMiddleboro$37K
- Ambareen JanBurlington$19K
- Neeraj KohliWellesley$17K
- Anthony DisciulloCambridge$8K
- Amy McGaraghanPeabody$6K
- Stephanie MorrisNewton$5K
- Louise KingBoston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.